Jan-Luuk Hillebrands

Author PubWeight™ 37.79‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Viral infections as potential triggers of type 1 diabetes. Diabetes Metab Res Rev 2007 1.65
2 Pericyte migration: a novel mechanism of pericyte loss in experimental diabetic retinopathy. Diabetes 2008 1.36
3 Hydrogen sulfide-induced hypometabolism prevents renal ischemia/reperfusion injury. J Am Soc Nephrol 2009 1.25
4 Cystathionine γ-lyase protects against renal ischemia/reperfusion by modulating oxidative stress. J Am Soc Nephrol 2013 1.16
5 The clinical relevance of assessing advanced glycation endproducts accumulation in diabetes. Cardiovasc Diabetol 2008 1.16
6 UMOD as a susceptibility gene for end-stage renal disease. BMC Med Genet 2012 1.06
7 Infections that induce autoimmune diabetes in BBDR rats modulate CD4+CD25+ T cell populations. J Immunol 2003 1.05
8 Bone marrow does not contribute substantially to endothelial-cell replacement in transplant arteriosclerosis. Nat Med 2002 0.98
9 Differential expression of proteoglycans in tissue remodeling and lymphangiogenesis after experimental renal transplantation in rats. PLoS One 2010 0.95
10 SREBP-1c expression in Schwann cells is affected by diabetes and nutritional status. Mol Cell Neurosci 2007 0.94
11 Vasoregression linked to neuronal damage in the rat with defect of polycystin-2. PLoS One 2009 0.93
12 Images in cardiovascular medicine. Multispectral near-infrared fluorescence molecular imaging of matrix metalloproteinases in a human carotid plaque using a matrix-degrading metalloproteinase-sensitive activatable fluorescent probe. Circulation 2009 0.90
13 Gaseous hydrogen sulfide protects against myocardial ischemia-reperfusion injury in mice partially independent from hypometabolism. PLoS One 2013 0.90
14 CUBN as a novel locus for end-stage renal disease: insights from renal transplantation. PLoS One 2012 0.89
15 Decreased hypoxia-induced neovascularization in angiopoietin-2 heterozygous knockout mouse through reduced MMP activity. Cell Physiol Biochem 2009 0.89
16 Accumulation of advanced glycation end products and chronic complications in ESRD treated by dialysis. Am J Kidney Dis 2008 0.89
17 Aldosterone, from (patho)physiology to treatment in cardiovascular and renal damage. Curr Vasc Pharmacol 2011 0.88
18 Beneficial effects of gaseous hydrogen sulfide in hepatic ischemia/reperfusion injury. Transpl Int 2012 0.88
19 Current imaging modalities to visualize vulnerability within the atherosclerotic carotid plaque. J Vasc Surg 2008 0.87
20 Lectin complement pathway gene profile of the donor and recipient does not influence graft outcome after kidney transplantation. Mol Immunol 2011 0.84
21 ADAM17 up-regulation in renal transplant dysfunction and non-transplant-related renal fibrosis. Nephrol Dial Transplant 2011 0.84
22 Thymectomy should be the first choice in the protection of diabetes-prone BB rats for breeding purposes. Lab Anim 2004 0.84
23 Rosiglitazone attenuates transplant arteriosclerosis after allogeneic aorta transplantation in rats. Transplantation 2007 0.83
24 d-Asb11 is an essential mediator of canonical Delta-Notch signalling. Nat Cell Biol 2008 0.83
25 Development of transplant vasculopathy in aortic allografts correlates with neointimal smooth muscle cell proliferative capacity and fibrocyte frequency. Atherosclerosis 2009 0.82
26 Circulating alpha-klotho levels are not disturbed in patients with type 2 diabetes with and without macrovascular disease in the absence of nephropathy. Cardiovasc Diabetol 2013 0.82
27 Angiogenic sprouting from the aortic vascular wall is impaired in the BB rat model of autoimmune diabetes. Microvasc Res 2007 0.82
28 Genetic analysis of mesangial matrix expansion in aging mice and identification of Far2 as a candidate gene. J Am Soc Nephrol 2013 0.81
29 SLC22A2 is associated with tubular creatinine secretion and bias of estimated GFR in renal transplantation. Physiol Genomics 2013 0.80
30 Single-chain VEGF/Cy5.5 targeting vegf receptors to indicate atherosclerotic plaque instability. Mol Imaging Biol 2013 0.80
31 Donor and recipient contribution to transplant vasculopathy in chronic renal transplant dysfunction. Transplantation 2009 0.80
32 CORMs protect endothelial cells during cold preservation, resulting in inhibition of intimal hyperplasia after aorta transplantation in rats. Transpl Int 2010 0.79
33 Targeted inhibition of renal Rho kinase reduces macrophage infiltration and lymphangiogenesis in acute renal allograft rejection. Eur J Pharmacol 2012 0.78
34 Renal heparan sulfate proteoglycans modulate fibroblast growth factor 2 signaling in experimental chronic transplant dysfunction. Am J Pathol 2013 0.78
35 Non-bone marrow origin of neointimal smooth muscle cells in experimental in-stent restenosis in rats. J Vasc Res 2008 0.78
36 Spironolactone ameliorates transplant vasculopathy in renal chronic transplant dysfunction in rats. Am J Physiol Renal Physiol 2009 0.78
37 Comment on "Type 1 diabetes in BioBreeding rats is critically linked to an imbalance between Th17 and regulatory T cells and an altered TCR repertoire". J Immunol 2011 0.77
38 Dichotomous effects of rosiglitazone in transplantation-induced systemic vasodilator dysfunction in rats. Transplantation 2008 0.76
39 N-octanoyl Dopamine Attenuates the Development of Transplant Vasculopathy in Rat Aortic Allografts Via Smooth Muscle Cell Protective Mechanisms. Transplantation 2016 0.76
40 The source of neointimal cells in vein grafts: does the origin matter? Am J Pathol 2008 0.76
41 Pharmacological Inhibition of Vanin Activity Attenuates Transplant Vasculopathy in Rat Aortic Allografts. Transplantation 2016 0.76
42 Hydrogen sulfide in hypertension. Curr Opin Nephrol Hypertens 2016 0.75
43 Novel insights in localization and expression levels of C5aR and C5L2 under native and post-transplant conditions in the kidney. Mol Immunol 2012 0.75
44 Long-term type 1 diabetes enhances in-stent restenosis after aortic stenting in diabetes-prone BB rats. J Biomed Biotechnol 2011 0.75
45 Cytomegalovirus infection modulates cellular immunity in an experimental model for autoimmune diabetes. Clin Dev Immunol 2004 0.75
46 Human Cytomegalovirus-Encoded Receptor US28 Is Expressed in Renal Allografts and Facilitates Viral Spreading In Vitro. Transplantation 2017 0.75